Chester County News and Community Website
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has reached a significant milestone in its Advance-HTN trial by hitting its enrollment target of 261 participants. This pivotal trial is crucial in …
Mineralys Therapeutics Hits Enrollment Milestone in Hypertension Drug Trial Read More RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) this week announced its financial results for the second quarter ending June 30, 2024, and provided a corporate update, highlighting significant progress …
Mineralys Therapeutics Posts Q2 Financial Results, Updates on Clinical Trials Read More RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS) announced the appointment of Alexander M. Gold, M.D., to its Board of Directors, effective June 13, 2024. His addition comes as the …
Mineralys Therapeutics Appoints Dr. Alexander Gold to Board Amid Hypertension Drug Development Read More RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a leading biopharmaceutical company, this week announced its impressive financial results and corporate developments for the first quarter ending March 31, 2024.
Mineralys Therapeutics Reports Robust Financial Results for Q1 2024 Read More